-
Global Biopharma Layoffs March 2026
Layoffs
Global Biopharma companies including Merck, Baye, and Novartis announce workforce reductions in March 2026 as part of cost-saving and strategic realignments, impacting research, technology, and leadership roles across their operations.
-
Merck Full Year 2025 Financial Report
Merck
Merck's 2025 performance shows 1% revenue growth, driven by strong sales of KEYTRUDA, new products like WINREVAIR, and growth in animal health. The company maintains cautious optimism for 2026 amid challenges like patent cliffs and currency fluctuations.
-
Global Biopharma Layoffs November 2025
Layoffs
This article tracks recent biotech and pharma layoffs, including major workforce cuts at Novo Nordisk, Takeda, GSK, Pharming, and others, as companies restructure operations, streamline pipelines, and refocus resources amid shifting market conditions.
-
-
-
Global Biopharma Layoffs July 2025
Layoffs
Biopharmaceutical industry sees major July layoffs, with companies like Sarepta, GSK, Century, and Sage Therapeutics cutting jobs amid restructurings, trial setbacks, and M&A activity.
-
-
-
-
若尔盖县|
志丹县|
晋中市|
永清县|
德钦县|
永修县|
阿图什市|
龙门县|
隆化县|
洪江市|
玉龙|
宁津县|
家居|
东平县|
绥德县|
泰州市|
龙门县|
轮台县|
原平市|
高密市|
新津县|
巴马|
萝北县|
普宁市|
南木林县|
芜湖市|
鄄城县|
大足县|
镇康县|
奎屯市|
麻阳|
井陉县|
广灵县|
延寿县|
宜黄县|
滕州市|
祁东县|
乐至县|
美姑县|
芦山县|
重庆市|